Shang J, Xu Y-D, Zhang Y-Y, Li M
Department of Central Sterile Supply, Yantai Yuhuangding Hospital, Yantai, China.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):11989. doi: 10.26355/eurrev_202012_23973.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1, by J. Shang, Y.-D. Xu, Y.-Y. Zhang, M. Li, published in Eur Rev Med Pharmacol Sci 2019; 23 (10): 4220-4225-DOI: 10.26355/eurrev_201905_17926-PMID: 31173293" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/17926.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们要求证明数据和图表原创性的请求，“J. Shang、Y.-D. Xu、Y.-Y. Zhang、M. Li发表于《欧洲医学与药理学评论》2019年；23(10): 4220 - 4225 - DOI: 10.26355/eurrev_201905_17926 - PMID: 31173293的‘长链非编码RNA OR3A4通过上调CDK1促进非小细胞肺癌顺铂耐药性’”已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/17926
